Show Abstract ▼

Abstract: Glucocorticoid (or steroid) induced osteoporosis (GIOP) is the leading form of secondary osteoporosis, affecting up to 50% of patients receiving chronic glucocorticoid therapy. Bone quantity (bone mass) changes in GIOP patients alone are inadequate to explain the increased fracture risk, and bone material changes (bone quality) at multiple levels have been implicated in the reduced mechanics. Quantitative analysis of specific material-level changes is limited. Here, we combined multiscale experimental techniques (scanning small/wide-angle X-ray scattering/diffraction, backscattered electron imaging, and X-ray radiography) to investigate these changes in a mouse model (Crh−120/+) with chronic endogenous steroid production. Nanoscale degree of orientation, the size distribution of mineral nanocrystals in the bone matrix, the spatial map of mineralisation on the femoral cortex, and the microporosity showed significant changes between GIOP and the control, especially in the endosteal cortex. Our work can provide insight into the altered structure-property relationship leading to lowered mechanical properties in GIOP.

Show Abstract ▼

Abstract: As bone is used in a dynamic mechanical environment, understanding the structural origins of its time-dependent mechanical behaviour – and the alterations in metabolic bone disease – is of interest. However, at the scale of the mineralized fibrillar matrix (nanometre-level), the nature of the strain-rate dependent mechanics is incompletely understood. Here, we investigate the fibrillar- and mineral-deformation behaviour in a murine model of Cushing’s syndrome, used to understand steroid induced osteoporosis, using synchrotron small- and wide-angle scattering/diffraction combined with in situ tensile testing at three strain rates ranging from 10-4 to 10-1 s-1. We find that the effective fibril- and mineral-modulus and fibrillar-reorientation show no significant increase with strain-rate in osteoporotic bone, but increase significantly in normal (wild-type) bone. By applying a fibril-lamellar two-level structural model of bone matrix deformation to fit the results, we obtain indications that altered collagen-mineral interactions at the nanoscale – along with altered fibrillar orientation distributions – may be the underlying reason for this altered strain-rate sensitivity. Our results suggest that an altered strain-rate sensitivity of the bone matrix in osteoporosis may be one of the contributing factors to reduced mechanical competence in such metabolic bone disorders, and that increasing this sensitivity may improve biomechanical performance.

Open Access

Show Abstract ▼

Abstract: Individuals with the rare developmental disorder fibrodysplasia ossificans progressiva (FOP) experience disabling heterotopic ossification caused by a gain of function mutation in the intracellular region of the BMP type I receptor kinase ALK2, encoded by the gene ACVR1. Small molecule BMP type I receptor inhibitors that block this ossification in FOP mouse models have been derived from the pyrazolo[1,5-a]pyrimidine scaffold of dorsomorphin. While the first derivative LDN-193189 exhibited pan inhibition of BMP receptors, the more recent compound LDN-212854 has shown increased selectivity for ALK2. Here we solved the crystal structure of ALK2 in complex with LDN-212854 to define how its binding interactions compare to previously reported BMP and TGFβ receptor inhibitors. LDN-212854 bound to the kinase hinge region as a typical type I ATP-competitive inhibitor with a single hydrogen bond to ALK2 His286. Specificity arising from the 5-quinoline moiety was associated with a distinct pattern of water-mediated hydrogen bonds involving Lys235 and Glu248 in the inactive conformation favoured by ALK2. The structure of this complex provides a template for the design of future ALK2 inhibitors under development for the treatment of FOP and other related conditions of heterotopic ossification.

Open Access

Show Abstract ▼

Abstract: Farnesyl pyrophosphate synthase (FPPS) is the major molecular target of nitrogen-containing bisphosphonates (N-BPs), used clinically as bone resorption inhibitors. We investigated the role of threonine 201 (Thr201) and tyrosine 204 (Tyr204) residues in substrate binding, catalysis and inhibition by N-BPs, employing kinetic and crystallographic studies of mutated FPPS proteins. Mutants of Thr201 illustrated the importance of the methyl group in aiding the formation of the Isopentenyl pyrophosphate (IPP) binding site, while Tyr204 mutations revealed the unknown role of this residue in both catalysis and IPP binding. The interaction between Thr201 and the side chain nitrogen of N-BP was shown to be important for tight binding inhibition by zoledronate (ZOL) and risedronate (RIS), although RIS was also still capable of interacting with the main-chain carbonyl of Lys200. The interaction of RIS with the phenyl ring of Tyr204 proved essential for the maintenance of the isomerized enzyme-inhibitor complex. Studies with conformationally restricted analogues of RIS reaffirmed the importance of Thr201 in the formation of hydrogen bonds with N-BPs. In conclusion we have identified new features of FPPS inhibition by N-BPs and revealed unknown roles of the active site residues in catalysis and substrate binding.

Show Abstract ▼

Abstract: Limitations associated with current clinical fracture risk assessment tools highlight the need for increased understanding of the fracture mechanisms of the bone and, ideally, a means of assessing this in vivo. Being a multi-layered hierarchical structure, the overall properties of the bone are dictated by its structural and compositional properties over multiple length scales. In this study, we investigate the osteonal-, micro- and tissue-level mechanical behaviour of cortical bone tissue samples from young and elderly donors through atomic force microscope (AFM) cantilever-based nanoindentation, reference point microindentation (RPI) and fracture toughness experiments respectively. We demonstrate that bone's fracture toughness and crack growth resistance at the tissue-level are significantly correlated to damage susceptibility at the micro-level, and mechanical inhomogeneity between lamellae and interlamellar areas at the osteonal-level. In more detail, reduced nanoelasticity inhomogeneity of lamellar/interlamellar layers within the osteons correlated to increased indentation depth at the micro-level and an overall reduction in crack-growth toughness and fracture toughness of the tissue. Our data also suggest that deterioration of bone's mechanical properties is expressed concurrently at these three levels, and that mechanical inhomogeneity between the principal structural units of the cortical tissue holds a key role on bone's toughness behaviour. We hypothesise that the reduction in nanoelasticity inhomogeneity is - at least to some extent - responsible for the inability of the microstructure to effectively adapt to the applied load, e.g. by redistributing strains, in a non-catastrophic manner preventing damage formation and propagation. Our hypothesis is further supported by synchrotron radiation micro-computed tomography (SRμCT) data, which show that failure of tougher bone specimens is governed by increased deflection of the crack path and broadly spread damage around the crack-tip. In contrast, shorter and more direct crack paths as well as less-distributed damage were evidenced during failure of the weaker specimens. Overall, this multi-scale study highlights the importance of elasticity inhomogeneity within the osteon to the damage susceptibility and consequently to the fracture resistance of the tissue.